Genetic and clinical advances in Prader-Willi syndrome

Current Opinion in Pediatrics

Volumn 8, Issue 6, 1996, Pages 618-624

  Wharton, Robert H ^a   Loechner, Karen J ^a  

^a and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

CHROMOSOME 15Q; CHROMOSOME DELETION; DISOMY; GENE EXPRESSION; GENETICS; GROWTH HORMONE RELEASE; HORMONAL THERAPY; HORMONE RESPONSE; HUMAN; MEDICAL RESEARCH; PATHOGENESIS; PRADER WILLI SYNDROME; PRIORITY JOURNAL; REVIEW;

EID: 0030458344     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199612000-00013     Document Type: Review

References (54)

1. Knoll JHM, Nicholls RD, Magenis RE, Graham JM Jr, Lalande M, Latt SA: Angelman and Prader-Willi syndromes share a common chromosome deletion but differ in parental origin of the deletion. Am J Med Genet 1989, 47:285-290.
2. Wharton RH, Bresnan MJ: Neonatal respiratory depression and delay in diagnosis in Prader-Willi syndrome. Dev Med Child Neurol 1989, 31:231-236.
3. Swaab DF, Purba JS, Hoffman MA: Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J Clin Endocrinol Metabol 1995, 80:573-579. Interesting study that reports some of the first autopsy data on the immunochemistry of brain tissue in persons with PWS. The paper is weakened by incomplete proof of the presence of PWS in study patients as well as by a poor control group. Nevertheless, conclusions point in an interesting and perhaps an important direction for future research.
4. Wharton RH, Levine K, Fragala M, Mulcahy DC: The child with Prader-Willi syndrome: birth to three. In Prader-Willi Syndrome Information Series, No 3. Edited by Tarakan SL, Maldonado J. New York: Prader-Willi Syndrome Perspectives; 1995:1-19.
5. Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY, Greenswag F: Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 1993, 91:398-402.
6. Hall JG: Genomic imprinting and its clinical implications. N Engl J Med 1992, 326:827-829.
7. Nicholls RD, Knoll JH, Glatt K, Hersh JH, Brewster TD, Graham JM Jr, Wurster-Hill D, Wharton RH, Latt SA: Restriction fragment length polymorphisms within proximal 15q and their use in molecular cytogenetics and the Prader-Willi syndrome. Am J Med Genet 1989, 33:66-77.
8. Butler MG: Prader-Willi syndrome: current understanding of cause and diagnosis. Am J Med Genet 1990, 35:319-335.
9. Magenis ER, Toth-Fejel S, Allen LJ, Black M, Brown MG, Budden S, Cohen R, Friedman JM, Kalousek D, Zonana J, et al.: Comparison of the 15q deletions in Prader-Willi and Angelman syndromes: specific regions, extent of deletions, parental origin, and clinical consequences. Am J Med Genet 1990, 35:333-349.
10. Mascari MJ, Gottlieb W, Rogan PK, Butler MG, Waller DA, Armour JAL, Jeffreys AJ, Ladda RL, Nicholls RD: The frequency of uniparental disomy in Prader-Willi syndrome: implications for molecular diagnosis. N Engl J Med 1992, 326:1599-1607.
11. Robinson WP, Bottani A, Yagang X, Balakrishman J, Binkert F, Machler M, Prader A, Schnizel A: Molecular, cytogenetic, and clinical investigations of Prader-Willi syndrome patients. Am J Hum Genet 1991, 49:1219-1234.
12. Nicholls RD, Knoll JH, Butler MG, Karam S, Lalande M: Genetic imprinting suggested by maternal uniparental heterodisomy in nondeletion Prader-Willi syndrome. Nature 1989, 342:281-285.
13. Reis A, Dittrich B, Greger V, Buiting K, Lalande M, Gillessen-Kaesbach G, Anvret M, Horsthemke B: Imprinting mutations suggested by abnormal DNA methylation patterns in familial Angelman and Prader-Willi syndromes. Am J Hum Genet 1994, 54:741-747.
14. Glenn CC, Driscoll DJ, Yang TP, Nicholls RD: Genomic imprinting in the Prader-Willi and Angelman syndromes. Molec Hum Reprod, in press. This review describes in detail the various genetic mechanisms that result in PWS and Angelman syndrome and the genes discovered in patients with PWS. It also describes the imprinting center, a novel genetic element that controls the initial resetting of the parental imprint in the germline for all imprinted gene expression over a 1.5-2.5 Mb region within chromosome 15q11-q13.
15. Buiting K, Saitoh S, Gross S, Dittruch B, Schwartz S, Nicholls RD, Horsthemke B: Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting center on human chromosome 15. Nat Genet 1995, 9:395-400. The authors present data on three persons with PWS and two persons with Angelman syndrome who have inherited microdeletions within chromosome 15q11-q13. They propose that 15q11-q13 contains a single imprinting center rather than separate paternal and maternal imprinting control elements.
16. Saitoh S, Buiting K, Rogan PK, Buxton JL, Driscoll DJ, Arnemann J, Konig R, Malcolm S, Horsthemke B, Nicholls RD: Minimal definition of the imprinting center and fixation of a chromosome 15q11-q13 epigenotype by imprinting mutations. Proc Natl Acad Sci U S A 1996, 93:7811-7815. This paper describes four new microdeletions of the imprinting center. The data presented here strongly support a model in which the paternal chromosome in PWS can carry an ancestral maternal epigenotype and the maternal chromosome of persons with Angelman syndrome may carry an ancestral paternal epigenotype.
17. Prader A, Labhart A, Willi H: Ein Syndrom von adipositasm Kleinwuchs, Kryptorchismus und Oligophrenie nach myotonieartigem Zustand in Neugeborenenalter. Schweiz Med Wochenschr 1956, 86:1260-1261.
18. Ridler MAC, Garrod O, Berg JM: A case of Prader-Willi syndrome in a girl with a small extra chromosome. Acta Paediatr Scand 1971, 60:222-226.
19. Biasini G, Vullo C, Petrone M, Agosti E, Nonato MG: Le syndrome de Prader, Labhart et Willi existe-t-il? Pediatrie 1975, 30:695-703.
20. Hawkey CJ, Smithies A: The Prader-Willi syndrome with a 15/15 translocation: case report and review of the literature. J Med Genet 1976, 13:152-156.
21. Ledbetter DH, Riccardi VM, Airhart SD, Strobel RJ, Keenan BS, Crawford JD: Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. N Engl J Med 1981, 304:325-329.
22. Gottlieb W, Rogan PK, Driscoll DJ, Nicholls RD: Analysis of chromosome breakage mechanisms in Prader-Willi and Angelman syndromes [abstract]. Am J Hum Genet 1993, 53:1553.
23. Amos-Landgraf J, Gottlieb W, Rogan PK, Saitoh S, Nicholls RD: Chromosome breakage in Prader-Willi and Angelman syndrome deletions may involve recombinations between a repeat at the proximal and distal breakpoints [abstract]. Am J Hum Genet 1994, 55:38.
24. Christian S, Robinson WP, Huang B, Mutirangura A, Line MR, Nakao M, Surti U, Chakravarti A, Ledbetter DH: Molecular characterization of two proximal deletion breakpoint regions in Prader-Willi and Angelman syndrome patients. Am J Hum Genet 1995, 57:40-48.
25. Butler MG, Palmer CG: Parental origin of chromosome 15 deletion in Prader-Willi syndrome. Lancet 1983, 1:185-186.
26. Purvis-Smith SG, Saville T, Manass S, Yip MY, Lam-Po-Tang P, Duffy B, Johnson H, Leigh D, McDonald B: Uniparental disomy 15 resulting from "correction" of an initial trisomy 15. Am J Hum Genet 1992, 50:1348-1350.
27. Cassidy SB, Lai LW, Erickson RP, Magnuson L, Thomas G, Gendron R, Herrmann J: Trisomy 15 with loss of the parental 15 as a cause of Prader-Willi syndrome due to maternal disomy. Am J Hum Genet 1992, 51:701-708.
28. Nicholls RD: Genomic imprinting and uniparental disomy in Angelman and Prader-Willi syndromes: a review. Am J Med Genet 1993, 46:16-25.
29. Toth-Fejel S, Olson S, Gunter K, Quan F, Wolford J, Popovich BW, Magenis RE: The impact of imprinting: Prader-Willi syndrome resulting from chromosome translocation, recombination and nondisjunction. Am J Hum Genet 1996, 58:1008-1016. A report of two cases of PWS with UPD in which a meiosis I nondisjunction error involving an altered chromosome 15 produced by both a translocation event and recombination was detected. The authors suggest that the structural rearrangements of the chromosome disrupted normal segregation of an imprinted region, resulting in UPD and PWS.
30. Magenis RE, Chamberlain J: Parental origin of non disjunction. In Trisomy 21 (Down Syndrome) Research Prospectives. Edited by de la Cruz FF, Gerald PS. Baltimore: University Park Press; 1981:77-93.
31. Nicholls RD: Imprinting mechanisms and genes involved in Prader-Willi and Angelman syndromes. Dev Biol 1994, 5:311-322.
32. Cattanach BM, Barr JA, Evans EP, Burtenshaw M, Beechey CV, Leff SE, Brannan CI: A candidate mouse model for Prader-Willi syndrome which shows an absence of Snrpn expression. Nat Genet 1992, 2:270-274.
33. Glenn CC, Saitoh S, Jong MTC, Filbrandt MM, Surti U, Driscoll DJ, Nicholls RD: Gene structure, DNA methylation, and imprinted expression of the human SNRPN gene. Am J Hum Genet 1996, 58:335-346. The authors characterize two previously unidentified 5′ exons of the Snrpn gene. They report that this Snrpn gene is expressed in a wide range of somatic tissues and at high, approximately equal levels in all regions of the brain. Their findings are consistent with a key role for DNA methylation in the imprinted inheritance and subsequent gene expression of the human Snrpn gene.
34. Glenn CC, Porter KA, Jong MTC, Nicholls RD, Driscoll DJ: Functional Imprinting and epigenetic modification of the human SNRPN gene. Hum Mol Genet 1993, 2:2001-2005.
35. Ozcelik T, Leff S, Robinson W, Donlon T, Lalande M, Sanjines E, Schnizel A, Francke U: Small nuclear ribonucleoprotein N (SNRPN), an expressed gene in the Prader-Willi critical region. Nat Genet 1992, 2:265-269.
36. Sutcliffe JS, Nakap M, Christian S, Orstavik H, Tommerup N, Ledbetter DH, Beaudet AL: Deletions of a differentially methylated CpG island at the SNRPN gene defines a putative imprinting control region. Nat Genet 1994, 8:52-58.
37. Kubota T, Aradhya S, Macha M, Smith ACM, Surh LC, Satish J, Verp MS, Johnson A, Christian SL, Ledbetter DH: Analysis of parent-of-origin specific DNA methytation at SNRPN and PW71 in tissues: Implication for prenatal diagnosis [abstract]. In Prader-Willi Syndrome Association Scientific Conference Proceedings. St. Louis: Prader-Willi Syndrome Association of North America; 1996. Reports that Snrpn methylation analysis may be useful for the diagnosis of PWS in cultured amniotic fluid or chorionic villus samples and that it will allow, for the first time, prenatal diagnosis for families known to carry imprinting center defects.
38. Ishikawa T, Kite T, Wada Y: Deletion of small nuclear ribonucleoprotein polypeptide N (SNRPN) in Prader-Willi syndrome detected by fluorescence in situ hybridization: two sibs with the typical phenotype without a cytogenetic deletion in chromosome 15. Am J Med Genet 1996, 62:350-352. A description of two siblings with typical PWS in whom a small deletion was detected in the PWS critical region by using FISH with a Snrpn gene probe. The authors suggest that this method will permit analysis of persons strongly suspected of having PWS in whom deletions are not detectable by other probes.
39. Cassidy SB: Prader-Willi syndrome. Curr Probl Pediatr 1983, 14:1-55.
40. Donaldson MDC, Chu CE, Cooke A, Wilson A, Greene SA, Stephenson JBP: The Prader-Willi syndrome. Arch Dis Child 1994, 70:58-63.
41. Wu RH, St. Louis Y, Rubin K, Cassidy SB, Thorpy MJ, Saenger P: Growth hormone therapy in Prader-Willi syndrome (PWS) [abstract]. Pediatr Res 1988, 23:207A.
42. Lee PDK, Wilson DM, Hintz RL, Rosenfeld RG: Growth hormone treatment of short stature in Prader-Willi syndrome. J Pediatr Endocrinol 1987, 2:31-34.
43. Cappa M, Grossi A, Borrelli P, Ghigo E, Bellone J, Benedetti S, Carta D, Loche S: Growth hormone (GH) response to combined GH-releasing hormone administration in patients with Prader-Labhart-Willi syndrome. Horm Res 1993, 39:51-55.
44. Ruvulcaba RHA, Holm VA: Effects of growth hormone in Prader-Willi syndrome. Clin Pediatr 1993, 32:292-295.
45. Vanderscheuren-Lodeweyckx M: The effect of simple obesity on growth and growth hormone. Horm Res 1993, 40:23-30.
46. Veldhuis JD, Liem AY, South S, Weltman A, Weltman J, Clemmons DA, Abbott R, Mulligan T, Johnson ML, Pincus S, et al.: Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab 1995, 80:3209-3222.
47. Costeff H, Holm VA, Ruvulcaba R, Shaver J: Growth hormone secretion in Prader-Willi syndrome. Acta Paediatr Scand 1990, 79:1059-1062.
48. Angulo M, Castro-Magana M, Uy J: Pituitary evaluation and growth hormone treatment in Prader-Willi syndrome. J Pediatr Endocrinol 1991, 4:167-173.
49. Lindgren AC, Hagenas L, Muller J, Blichfeldt S, Lindqvist MA, Ritzen EM: Growth hormone treatment in Prader-Willi syndrome: a controlled study. Horm Ras 1995, 44:61. This is the only controlled study to date that has evaluated the effects of growth hormone therapy in prepubertal children with PWS. Growth hormone test results, including IGF-1 levels, are reported for both children with PWS and obese control subjects. The positive effects of growth hormone on growth velocity, IGF-1 levels, and body mass index are reported. Similar studies of longer duration are still necessary to provide information about long-term benefits and improvement in final adult height in this population of children with PWS.
50. Jorgensen JOL, Thuesen L, Ingemann-Hansen T, Pedersen SA, Jorgensen J, Skakkebaek NE, Christiansen JS: Beneficial effects of growth hormone treatment in QH-deficient adults. Lancet 1989, 1:1221-1224.
51. Saloman F, Cuneo RC, Heap R, Sonksen PH: The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989, 321:1797-1803.
52. Bengtsson B-A, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tolli J, Sjostrom L, Isaksson S: Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993, 76:309-317.
53. Tanner JM, Hughes PRCR, Whitehouse RH: Comparative rapidity of response of height, limb muscle and limb fat to treatment with human growth hormone in patients with and without growth hormone deficiency. Acta Endocrinol 1977, 84:681-696.
54. Lawson Wilkins Pediatric Endocrine Society: Guidelines for the use of growth hormone in children with short stature. J Pediatr 1995, 127:857-867. A consensus guideline from the Lawson Wilkins Pediatric Endocrine Society and the American Academy of Pediatrics for the use of growth hormone in children with short stature of various causes, including PWS. Data on efficacy and reported side effects of growth hormone treatment are provided.